Gary Taubes

Este archivo solo abarca los artículos del autor incorporados a este sitio a partir del 1 de diciembre de 2006. Para fechas anteriores realice una búsqueda entrecomillando su nombre.

Diced peaches are coated with sugar for a frozen yogurt recipe being tried out in the Los Angeles Times test kitchen in 2016. (Los Angeles Times)

InternacionalSalud Pública

Sugar may well be a killer. The conventional thinking is that it’s an “empty calorie” — it fills you up without providing nutrients. But there’s a growing body of research suggesting that sugar actually triggers a disorder known as metabolic syndrome, which the Centers for Disease Control and Prevention says now afflicts 75 million Americans. If it does, then it plays a critical role in virtually every major chronic disease, including obesity, diabetes, heart disease, cancer and even dementia. The catch is that the evidence is ambiguous. At this point, scientists can’t tell us definitively whether this accusation against sugar is true.…  Seguir leyendo »

ReflexionesSocial,

A calorie is a calorie. This truism has been the foundation of nutritional wisdom and our beliefs about obesity since the 1960s.

What it means is that a calorie of protein will generate the same energy when metabolized in a living organism as a calorie of fat or carbohydrate. When talking about obesity or why we get fat, evoking the phrase “a calorie is a calorie” is almost invariably used to imply that what we eat is relatively unimportant. We get fat because we take in more calories than we expend; we get lean if we do the opposite. Anyone who tells you otherwise, by this logic, is trying to sell you something.…  Seguir leyendo »

InternacionalSalud Pública

The idea that cholesterol plays a key role in heart disease is so tightly woven into modern medical thinking that it is no longer considered open to question. This is the message that emerged all too clearly from the recent news that the drug Vytorin had fared no better in clinical trials than the statin therapy it was meant to supplant.

Vytorin is a combination of cholesterol-lowering drugs, one called Zetia and the other a statin called Zocor. Because the two drugs lower LDL cholesterol by different mechanisms, the makers of Vytorin (Merck and Schering-Plough) assumed that their double-barreled therapy would lower it more than either drug alone, which it did, and so do a better job of slowing the accumulation of fatty plaques in the arteries — which it did not.…  Seguir leyendo »